Create Alert
Watchlist
₹1,520.80
-0.20 (0.01%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
1,525.00
Prev. Close
1,521.00
Volume
8,13,485
Total traded value
124 Cr
Upper Circuit
1,673.10
Lower Circuit
1,368.90

Fundamentals

Market Cap₹1,22,878Cr
ROE16.53%
P/E Ratio(TTM)22.61
EPS(TTM)67.27
P/B Ratio3.73
Dividend Yield1.05%
Industry P/E33.37
Book Value407.53
Debt to Equity0.01
Face Value2
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Cipla

Founded in 1935, Cipla is a global pharmaceutical company driven by the purpose of making healthcare accessible to all. The company's vision is rooted in its belief that healthcare is a fundamental right, not a special privilege for a select few. It follows a compassionate approach to medicine that goes beyond just making profits, a principle that has guided it for 90 years. Its diverse product portfolio includes complex generic medicines for key health areas such as respiratory, anti-retroviral, urology, and cardiology. The company has a strong presence in its home markets of India, South Africa, and North America, along with other significant emerging markets. Cipla proudly stands as the third-largest pharmaceutical company in India and holds the second position in the prescription market in South Africa.;
Parent OrganisationCipla Limited
Managing DirectorMr Umang Vohra
Founded1935
NSE SymbolCIPLA

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Promoters
29.21%
Foreign Institutions
24.55%
Mutual Funds
20.23%
Retail And Others
15.99%
Other Domestic Institutions
10.01%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Sun Pharmaceutical Industries
NA
(0.00%)
41.62
Dr Reddy's Laboratories
NA
(0.00%)
18.58
Lupin
NA
(0.00%)
21.98
Zydus Lifesciences
NA
(0.00%)
18.71